Terns Pharmaceuticals, Inc. Common Stock

TERN

...

TERN: Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Show TERN Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of TERN by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by TERN's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on TERN's company Twitter account

WallStreetBets

Number of mentions of TERN in WallStreetBets Daily Discussion

TERN News

Recent insights relating to TERN

CNBC Recommendations

Recent picks made for TERN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TERN

Corporate Flights

Flights by private jets registered to TERN